Earlier this month Sanofi revealed talks were ongoing with CD&R, and has now confirmed the negotiations could result in the ...

AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with ...

Boston-based Seaport said the money would support a pipeline of improved neuropsychiatric drug candidates led by SPT-300, an ...

The increasing complexity of emerging therapies and the need for faster development have led to the adoption of advanced ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Following the discussion, attendees will have the opportunity to participate in a live Q&A session, further addressing ...

Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding ...

Vyloy is the first CLDN18.2-targeting drug to reach the US market but has already been approved in Japan as well as in the EU ...

A study has shown that Roche's diabetic macular oedema (DME) therapy Vabysmo is effective in patients who identify as African ...

The two FDA-approved apps – RESET and RESET-O – have been re-launched by new owner PursueCare, which acquired them as part of ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

In the study, clesrovimab (MK-1654) significantly reduced the incidence of RSV disease and hospitalisations in healthy ...